#21;(R)-2-[1-[(R)-2-[(1-((R)-2-(1-N-TERT.-BUTOXYCARBONYL-AMINO)-ETHYL-5-METHYLOXAZOLE-4-CARBONYL)-AMINO]-ISOBUTYLTHIAZOLE-4-CARBONYL]-AMINO]-ETHYLTHIAZOLE-4-CA
Compound with spectra: 1 NMR
![#21;(R)-2-[1-[(R)-2-[(1-((R)-2-(1-N-TERT.-BUTOXYCARBONYL-AMINO)-ETHYL-5-METHYLOXAZOLE-4-CARBONYL)-AMINO]-ISOBUTYLTHIAZOLE-4-CARBONYL]-AMINO]-ETHYLTHIAZOLE-4-CA](/api/compound/C20HVN8Z4F4.png?ph=true&h=300&w=458 "#21;(R)-2-[1-[(R)-2-[(1-((R)-2-(1-N-TERT.-BUTOXYCARBONYL-AMINO)-ETHYL-5-METHYLOXAZOLE-4-CARBONYL)-AMINO]-ISOBUTYLTHIAZOLE-4-CARBONYL]-AMINO]-ETHYLTHIAZOLE-4-CA")
| SpectraBase Compound ID | C20HVN8Z4F4 |
|---|---|
| InChI | InChI=1S/C26H34N6O7S2/c1-11(2)17(23-29-15(9-41-23)19(33)27-13(4)22-30-16(10-40-22)24(35)36)31-20(34)18-14(5)38-21(32-18)12(3)28-25(37)39-26(6,7)8/h9-13,17H,1-8H3,(H,27,33)(H,28,37)(H,31,34)(H,35,36)/t12-,13+,17+/m0/s1 |
| InChIKey | CISALVDPWLIUAG-OGHNNQOOSA-N |
| Mol Weight | 606.7 g/mol |
| Molecular Formula | C26H34N6O7S2 |
| Exact Mass | 606.19304 g/mol |
| Enantiomer InChIKey | CISALVDPWLIUAG-IGCXYCKISA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
VENTURAMIDE_A
BISTRATAMIDE-G
Nostocyclamide
Dendroamide B
MTGOPJUVBJTQFC-UAFMIMERSA-N
XQOQTYLICMGCBF-OALUTQOASA-N
(2S)-2-[4-[(1-carbomethoxy-2-keto-propyl)carbamoyl]-5-methyl-oxazol-2-yl]pyrrolidine-1-carboxylic acid benzyl ester
(BENZYLOXYCARBONYL)-GLU-(O-TERT.-BUTYL)-(THIAZOLE)-LYS-(TERT.-BUTYLOXYCARBONYL)-(OXAZOLE)-OME
2-(-1-Benzyloxycarbonylaminoethyl)-4-(T-butyl prolinyl-phenylalanyl-carboxy)-thiazole
MYEZDNALWNBXGM-IRXDYDNUSA-N
| Title | Journal or Book | Year |
|---|---|---|
| Total Synthesis of Dendroamide A, a Novel Cyclic Peptide That Reverses Multiple Drug Resistance | The Journal of Organic Chemistry | 2001 |